🦠 Vaccines: A Key Weapon Against Antimicrobial Resistance (AMR) A recent WHO report underscores the powerful role of vaccines in the fight against AMR, estimating that better use of vaccines could reduce the global need for antibiotics by 2.5 billion defined daily doses annually—a 22% decrease. This could be a game-changer in reducing the misuse
Despite the challenges posed by the ongoing conflict, Ukraine’s healthcare sector demonstrates remarkable resilience and adaptability. The country’s efforts to maintain and enhance its healthcare and research infrastructure are also keeping clinical trials on schedule. As we discussed in this article on Linkedin, over the past few decades, Ukraine has established itself as a strong option
I enjoy working as CRO and Trial Acceleration company in the highly challenging setting of Intensive Care – as agile, committed smaller companies we can show we make a difference and large CRO fail on the need to be fast and flexible. I attended this 43rd meeting of ISICEM to keep up in sepsis, more
Client 4SC AG: The Marketing Authorisation Application for resminostat has been accepted by the EMA as sufficient for examination. “Germany, 1 March 2024 – 4SC AG a biotech company improving the lives of patients suffering with advanced-stage cutaneous T-cell lymphoma (CTCL), announced today that that its MAA has been accepted by the EMA as sufficient
Are any of your clinical trials held back by slow recruitment? The start for a successful clinical study is to efficiently recruit and retain the study population. But participant enrolment issues are a major reason for trial terminations. Global data analysis of all terminated trials within ClinTrials Database reported 55% of trials were terminated due
Up to 70% of premature cancer deaths among women are preventable, WHO-led analysis shows. Key takeaways: Most premature cancer deaths among women are preventable: nearly seven in 10 premature cancer-related deaths among women could have been avoided through primary prevention, early detection, or suitable access to cancer care. Twice as many premature cancer deaths among
There are roughly 2,500 public medical facilities in Ukraine that have previously run international clinical trials, and it was an average of 500 clinical trials were ongoing in Ukraine each year, before 24 Feb 2022. In early April’ 2022, ClinicalTrials.gov listed more than 400 active trials with sites in Ukraine – now hundreds of clinical trials have been halted. But
When I moved to Estonia, I understood that the Baltic Sea is one of the most polluted bodies of water on Earth. Nutrient runoff causes algal blooms, depleting oxygen and making water dark and murky. Urban litter and industrial chemicals that end up in the sea harm its ecosystems. Overfishing and climate change have also added their
Sepsis remains one of the most common and least-recognized illnesses in both the developed and developing world. The Global Burden of Disease Sepsis Report published in January 2020 estimated that 49 million patients suffer sepsis every year, with 11 millions of those dying. This burden is significantly higher than the number of lives lost to
Its accounting for about 8 million deaths each year. Mortality for severe sepsis is between 15% and 30% in high-income countries with high standard of care and > 50% in low-income countries. And with significant morbidity. UK ICU Sepsis is a syndrome encompassing a spectrum of illness that ranges from minor signs and symptoms through
The Estonian Biobank has established a population-based biobank of Estonia with a current cohort size of more than 200,000 individuals (genotyped with genome-wide arrays), reflecting the age, sex and geographical distribution of the adult Estonian population. Because about 20% of Estonia’s adult population has joined the programme, it is a database that is important for
